🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
50.78
-0.68 (-1.32%)
At close: Nov 20, 2026, 4:00 PM EST
52.48
+1.70 (3.35%)
After-hours: Nov 20, 2026, 7:38 PM EST

Cytokinetics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
113.2988.0418.477.537.5970.43
Other Revenue
----87-
113.2988.0418.477.5394.5970.43
Revenue Growth
29.90%376.56%145.34%-92.04%34.30%26.15%
Cost of Revenue
407.38416.03339.41330.12240.81159.94
Gross Profit
-294.08-327.99-320.93-322.59-146.23-89.51
Selling, General & Admin
414.16284.27215.31173.61177.9896.8
Operating Expenses
414.16284.27215.31173.61177.9896.8
Operating Income
-708.24-612.26-536.25-496.21-324.2-186.31
Interest Expense
-136.99-103.87-86.51-57.67-51.16-29.33
Interest & Investment Income
52.3448.4251.5327.6311.340.33
Other Non Operating Income (Expenses)
154-18.3---
EBT Excluding Unusual Items
-777.89-663.71-589.53-526.24-364.02-215.31
Other Unusual Items
--121.25---24.94-
Pretax Income
-777.89-784.96-589.53-526.24-388.96-215.31
Net Income
-777.89-784.96-589.53-526.24-388.96-215.31
Net Income to Common
-777.89-784.96-589.53-526.24-388.96-215.31
Net Income Growth
------
Shares Outstanding (Basic)
129120112979077
Shares Outstanding (Diluted)
129120112979077
Shares Change
8.61%7.26%16.01%7.46%16.83%19.16%
EPS (Basic)
-6.02-6.54-5.26-5.45-4.33-2.80
EPS (Diluted)
-6.02-6.54-5.26-5.45-4.33-2.80
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-588.58-534.82-399.8-415.75-310.85-191.39
Free Cash Flow Per Share
-4.55-4.45-3.57-4.31-3.46-2.49
Gross Margin
-259.58%----154.59%-127.09%
Operating Margin
-625.15%-695.44%-2902.72%-6589.71%-342.75%-264.54%
Profit Margin
-686.63%-891.60%-3191.11%-6988.63%-411.21%-305.72%
Free Cash Flow Margin
-519.53%-607.48%-2164.10%-5521.23%-328.64%-271.76%
EBITDA
-694.73-602.13-526.72-484.31-318.39-184.04
EBITDA Margin
------261.31%
D&A For EBITDA
13.5210.139.5311.895.812.28
EBIT
-708.24-612.26-536.25-496.21-324.2-186.31
EBIT Margin
------264.54%
Revenue as Reported
113.2988.0418.477.5394.5970.43
SEC Filings: 10-K · 10-Q